Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-094856
Filing Date
2025-07-09
Accepted
2025-07-09 17:32:20
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2109
2 EX-24 apvo-ex24.htm EX-24 14971
  Complete submission text file 0000950170-25-094856.txt   18496
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Huebner Dirk (Reporting) CIK: 0001760345 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37746 | Film No.: 251114400